APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-benzodiazepine Hypnotics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Non-benzodiazepine Hypnotics Industry Growth and Trends Forecast to 2032

29 December 2025128 pages

Choose your research edition.

Industry ResearchNon-benzodiazepine Hypnotics Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-benzodiazepine Hypnotics Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Non-benzodiazepine Hypnotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-benzodiazepine Hypnotics Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-benzodiazepine Hypnotics Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Non-benzodiazepine Hypnotics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Non-benzodiazepine Hypnotics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Non-benzodiazepine Hypnotics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-benzodiazepine Hypnotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-benzodiazepine Hypnotics include Abbott, Tianjin Tasly Saint Pharmaceuticals, Sun Pharmaceutical, Shanghai Pharmaceuticals, Qilu Pharmaceutical, Kanghong Pharmaceuticals, Changzhou Siyao Pharmaceutical, Wockhardt and Torrent Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Non-benzodiazepine Hypnotics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Non-benzodiazepine Hypnotics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Non-benzodiazepine Hypnotics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Non-benzodiazepine Hypnotics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Non-benzodiazepine Hypnotics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Non-benzodiazepine Hypnotics Market by Company

Abbott

Tianjin Tasly Saint Pharmaceuticals

Sun Pharmaceutical

Shanghai Pharmaceuticals

Qilu Pharmaceutical

Kanghong Pharmaceuticals

Changzhou Siyao Pharmaceutical

Wockhardt

Torrent Pharma

Teva Pharmaceuticals

Tapi Teva

Sanofi-aventis

Northstar Rx

Mylan Pharmaceuticals

Kanghong Pharmaceutical

Hikma Pharmaceuticals

Glenmark Life Sciences

Endo

Dr. Reddy’s Laboratories

Centaur Pharmaceuticals

Apotex

Admiron Life

Non-benzodiazepine Hypnotics Segment by Type

Zaleplon

Zopiclone

Zolpidem

Other

Non-benzodiazepine Hypnotics Segment by Application

Hospital

Clinic

Other

Non-benzodiazepine Hypnotics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-benzodiazepine Hypnotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-benzodiazepine Hypnotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-benzodiazepine Hypnotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-benzodiazepine Hypnotics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Non-benzodiazepine Hypnotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Zaleplon Table 2. Major Company of Zopiclone Table 3. Major Company of Zolpidem Table 4. Major Company of Other Table 5. Global Non-benzodiazepine Hypnotics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Non-benzodiazepine Hypnotics Sales by Type (2021-2026) & (K Units) Table 7. Global Non-benzodiazepine Hypnotics Sales Market Share in Volume by Type (2021-2026) Table 8. Global Non-benzodiazepine Hypnotics Sales by Type (2021-2026) & (US$ Million) Table 9. Global Non-benzodiazepine Hypnotics Sales Market Share in Value by Type (2021-2026) Table 10. Global Non-benzodiazepine Hypnotics Price by Type (2021-2026) & (US$/Unit) Table 11. Global Non-benzodiazepine Hypnotics Sales by Type (2027-2032) & (K Units) Table 12. Global Non-benzodiazepine Hypnotics Sales Market Share in Volume by Type (2027-2032) Table 13. Global Non-benzodiazepine Hypnotics Sales by Type (2027-2032) & (US$ Million) Table 14. Global Non-benzodiazepine Hypnotics Sales Market Share in Value by Type (2027-2032) Table 15. Global Non-benzodiazepine Hypnotics Price by Type (2027-2032) & (US$/Unit) Table 16. North America Non-benzodiazepine Hypnotics Sales by Type (2021-2026) & (K Units) Table 17. North America Non-benzodiazepine Hypnotics Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Non-benzodiazepine Hypnotics Sales by Type (2021-2026) & (K Units) Table 19. Europe Non-benzodiazepine Hypnotics Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Non-benzodiazepine Hypnotics Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Non-benzodiazepine Hypnotics Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Non-benzodiazepine Hypnotics Sales by Type (2021-2026) & (K Units) Table 23. Latin America Non-benzodiazepine Hypnotics Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Non-benzodiazepine Hypnotics Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Non-benzodiazepine Hypnotics Sales by Type (2021-2026) & (US$ Million) Table 26. Non-benzodiazepine Hypnotics Industry Trends Table 27. Non-benzodiazepine Hypnotics Industry Drivers Table 28. Non-benzodiazepine Hypnotics Industry Opportunities and Challenges Table 29. Non-benzodiazepine Hypnotics Industry Restraints Table 30. Global Non-benzodiazepine Hypnotics Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Non-benzodiazepine Hypnotics Revenue Market Share by Company (2021-2026) Table 32. Global Non-benzodiazepine Hypnotics Sales by Company (2021-2026) & (K Units) Table 33. Global Non-benzodiazepine Hypnotics Sales Share by Company (2021-2026) Table 34. Global Non-benzodiazepine Hypnotics Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Non-benzodiazepine Hypnotics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Non-benzodiazepine Hypnotics Major Company Production Sites and Headquarters Table 37. Global Non-benzodiazepine Hypnotics Company, Product Type & Application Table 38. Global Non-benzodiazepine Hypnotics Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Non-benzodiazepine Hypnotics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Non-benzodiazepine Hypnotics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Non-benzodiazepine Hypnotics Sales by Region (2021-2026) & (K Units) Table 43. Global Non-benzodiazepine Hypnotics Sales Market Share in Volume by Region (2021-2026) Table 44. Global Non-benzodiazepine Hypnotics Sales by Region (2021-2026) & (US$ Million) Table 45. Global Non-benzodiazepine Hypnotics Sales Market Share in Value by Region (2021-2026) Table 46. Global Non-benzodiazepine Hypnotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Non-benzodiazepine Hypnotics Sales by Region (2027-2032) & (K Units) Table 48. Global Non-benzodiazepine Hypnotics Sales Market Share in Volume by Region (2027-2032) Table 49. Global Non-benzodiazepine Hypnotics Sales by Region (2027-2032) & (US$ Million) Table 50. Global Non-benzodiazepine Hypnotics Sales Market Share in Value by Region (2027-2032) Table 51. Global Non-benzodiazepine Hypnotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Non-benzodiazepine Hypnotics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Non-benzodiazepine Hypnotics Sales by Application (2021-2026) & (K Units) Table 54. Global Non-benzodiazepine Hypnotics Sales Market Share in Volume by Application (2021-2026) Table 55. Global Non-benzodiazepine Hypnotics Sales by Application (2021-2026) & (US$ Million) Table 56. Global Non-benzodiazepine Hypnotics Sales Market Share in Value by Application (2021-2026) Table 57. Global Non-benzodiazepine Hypnotics Price by Application (2021-2026) & (US$/Unit) Table 58. Global Non-benzodiazepine Hypnotics Sales by Application (2027-2032) & (K Units) Table 59. Global Non-benzodiazepine Hypnotics Sales Market Share in Volume by Application (2027-2032) Table 60. Global Non-benzodiazepine Hypnotics Sales by Application (2027-2032) & (US$ Million) Table 61. Global Non-benzodiazepine Hypnotics Sales Market Share in Value by Application (2027-2032) Table 62. Global Non-benzodiazepine Hypnotics Price by Application (2027-2032) & (US$/Unit) Table 63. North America Non-benzodiazepine Hypnotics Sales by Application (2021-2026) & (K Units) Table 64. North America Non-benzodiazepine Hypnotics Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Non-benzodiazepine Hypnotics Sales by Application (2021-2026) & (K Units) Table 66. Europe Non-benzodiazepine Hypnotics Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Non-benzodiazepine Hypnotics Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Non-benzodiazepine Hypnotics Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Non-benzodiazepine Hypnotics Sales by Application (2021-2026) & (K Units) Table 70. Latin America Non-benzodiazepine Hypnotics Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Non-benzodiazepine Hypnotics Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Non-benzodiazepine Hypnotics Sales by Application (2021-2026) & (US$ Million) Table 73. Abbott Company Information Table 74. Abbott Business Overview Table 75. Abbott Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Abbott Non-benzodiazepine Hypnotics Product Portfolio Table 77. Abbott Recent Development Table 78. Tianjin Tasly Saint Pharmaceuticals Company Information Table 79. Tianjin Tasly Saint Pharmaceuticals Business Overview Table 80. Tianjin Tasly Saint Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Tianjin Tasly Saint Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio Table 82. Tianjin Tasly Saint Pharmaceuticals Recent Development Table 83. Sun Pharmaceutical Company Information Table 84. Sun Pharmaceutical Business Overview Table 85. Sun Pharmaceutical Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sun Pharmaceutical Non-benzodiazepine Hypnotics Product Portfolio Table 87. Sun Pharmaceutical Recent Development Table 88. Shanghai Pharmaceuticals Company Information Table 89. Shanghai Pharmaceuticals Business Overview Table 90. Shanghai Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Shanghai Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio Table 92. Shanghai Pharmaceuticals Recent Development Table 93. Qilu Pharmaceutical Company Information Table 94. Qilu Pharmaceutical Business Overview Table 95. Qilu Pharmaceutical Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Qilu Pharmaceutical Non-benzodiazepine Hypnotics Product Portfolio Table 97. Qilu Pharmaceutical Recent Development Table 98. Kanghong Pharmaceuticals Company Information Table 99. Kanghong Pharmaceuticals Business Overview Table 100. Kanghong Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Kanghong Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio Table 102. Kanghong Pharmaceuticals Recent Development Table 103. Changzhou Siyao Pharmaceutical Company Information Table 104. Changzhou Siyao Pharmaceutical Business Overview Table 105. Changzhou Siyao Pharmaceutical Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Changzhou Siyao Pharmaceutical Non-benzodiazepine Hypnotics Product Portfolio Table 107. Changzhou Siyao Pharmaceutical Recent Development Table 108. Wockhardt Company Information Table 109. Wockhardt Business Overview Table 110. Wockhardt Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Wockhardt Non-benzodiazepine Hypnotics Product Portfolio Table 112. Wockhardt Recent Development Table 113. Torrent Pharma Company Information Table 114. Torrent Pharma Business Overview Table 115. Torrent Pharma Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Torrent Pharma Non-benzodiazepine Hypnotics Product Portfolio Table 117. Torrent Pharma Recent Development Table 118. Teva Pharmaceuticals Company Information Table 119. Teva Pharmaceuticals Business Overview Table 120. Teva Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Teva Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio Table 122. Teva Pharmaceuticals Recent Development Table 123. Tapi Teva Company Information Table 124. Tapi Teva Business Overview Table 125. Tapi Teva Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Tapi Teva Non-benzodiazepine Hypnotics Product Portfolio Table 127. Tapi Teva Recent Development Table 128. Sanofi-aventis Company Information Table 129. Sanofi-aventis Business Overview Table 130. Sanofi-aventis Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Sanofi-aventis Non-benzodiazepine Hypnotics Product Portfolio Table 132. Sanofi-aventis Recent Development Table 133. Northstar Rx Company Information Table 134. Northstar Rx Business Overview Table 135. Northstar Rx Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Northstar Rx Non-benzodiazepine Hypnotics Product Portfolio Table 137. Northstar Rx Recent Development Table 138. Mylan Pharmaceuticals Company Information Table 139. Mylan Pharmaceuticals Business Overview Table 140. Mylan Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Mylan Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio Table 142. Mylan Pharmaceuticals Recent Development Table 143. Kanghong Pharmaceutical Company Information Table 144. Kanghong Pharmaceutical Business Overview Table 145. Kanghong Pharmaceutical Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Kanghong Pharmaceutical Non-benzodiazepine Hypnotics Product Portfolio Table 147. Kanghong Pharmaceutical Recent Development Table 148. Hikma Pharmaceuticals Company Information Table 149. Hikma Pharmaceuticals Business Overview Table 150. Hikma Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Hikma Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio Table 152. Hikma Pharmaceuticals Recent Development Table 153. Glenmark Life Sciences Company Information Table 154. Glenmark Life Sciences Business Overview Table 155. Glenmark Life Sciences Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Glenmark Life Sciences Non-benzodiazepine Hypnotics Product Portfolio Table 157. Glenmark Life Sciences Recent Development Table 158. Endo Company Information Table 159. Endo Business Overview Table 160. Endo Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 161. Endo Non-benzodiazepine Hypnotics Product Portfolio Table 162. Endo Recent Development Table 163. Dr. Reddy’s Laboratories Company Information Table 164. Dr. Reddy’s Laboratories Business Overview Table 165. Dr. Reddy’s Laboratories Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 166. Dr. Reddy’s Laboratories Non-benzodiazepine Hypnotics Product Portfolio Table 167. Dr. Reddy’s Laboratories Recent Development Table 168. Centaur Pharmaceuticals Company Information Table 169. Centaur Pharmaceuticals Business Overview Table 170. Centaur Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 171. Centaur Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio Table 172. Centaur Pharmaceuticals Recent Development Table 173. Apotex Company Information Table 174. Apotex Business Overview Table 175. Apotex Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 176. Apotex Non-benzodiazepine Hypnotics Product Portfolio Table 177. Apotex Recent Development Table 178. Admiron Life Company Information Table 179. Admiron Life Business Overview Table 180. Admiron Life Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 181. Admiron Life Non-benzodiazepine Hypnotics Product Portfolio Table 182. Admiron Life Recent Development Table 183. North America Non-benzodiazepine Hypnotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 184. North America Non-benzodiazepine Hypnotics Sales by Country (2021-2026) & (K Units) Table 185. North America Non-benzodiazepine Hypnotics Sales Market Share by Country (2021-2026) Table 186. North America Non-benzodiazepine Hypnotics Sales Forecast by Country (2027-2032) & (K Units) Table 187. North America Non-benzodiazepine Hypnotics Sales Market Share Forecast by Country (2027-2032) Table 188. North America Non-benzodiazepine Hypnotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. North America Non-benzodiazepine Hypnotics Market Size by Country (2021-2026) & (US$ Million) Table 190. North America Non-benzodiazepine Hypnotics Market Share by Country (2021-2026) Table 191. North America Non-benzodiazepine Hypnotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. North America Non-benzodiazepine Hypnotics Market Share Forecast by Country (2027-2032) Table 193. Europe Non-benzodiazepine Hypnotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 194. Europe Non-benzodiazepine Hypnotics Sales by Country (2021-2026) & (K Units) Table 195. Europe Non-benzodiazepine Hypnotics Sales Market Share by Country (2021-2026) Table 196. Europe Non-benzodiazepine Hypnotics Sales Forecast by Country (2027-2032) & (K Units) Table 197. Europe Non-benzodiazepine Hypnotics Sales Market Share Forecast by Country (2027-2032) Table 198. Europe Non-benzodiazepine Hypnotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Europe Non-benzodiazepine Hypnotics Market Size by Country (2021-2026) & (US$ Million) Table 200. Europe Non-benzodiazepine Hypnotics Market Share by Country (2021-2026) Table 201. Europe Non-benzodiazepine Hypnotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Europe Non-benzodiazepine Hypnotics Market Share Forecast by Country (2027-2032) Table 203. Asia-Pacific Non-benzodiazepine Hypnotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 204. Asia-Pacific Non-benzodiazepine Hypnotics Sales by Country (2021-2026) & (K Units) Table 205. Asia-Pacific Non-benzodiazepine Hypnotics Sales Market Share by Country (2021-2026) Table 206. Asia-Pacific Non-benzodiazepine Hypnotics Sales Forecast by Country (2027-2032) & (K Units) Table 207. Asia-Pacific Non-benzodiazepine Hypnotics Sales Market Share Forecast by Country (2027-2032) Table 208. Asia-Pacific Non-benzodiazepine Hypnotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 209. Asia-Pacific Non-benzodiazepine Hypnotics Market Size by Country (2021-2026) & (US$ Million) Table 210. Asia-Pacific Non-benzodiazepine Hypnotics Market Share by Country (2021-2026) Table 211. Asia-Pacific Non-benzodiazepine Hypnotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 212. Asia-Pacific Non-benzodiazepine Hypnotics Market Share Forecast by Country (2027-2032) Table 213. Latin America Non-benzodiazepine Hypnotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 214. Latin America Non-benzodiazepine Hypnotics Sales by Country (2021-2026) & (K Units) Table 215. Latin America Non-benzodiazepine Hypnotics Sales Market Share by Country (2021-2026) Table 216. Latin America Non-benzodiazepine Hypnotics Sales Forecast by Country (2027-2032) & (K Units) Table 217. Latin America Non-benzodiazepine Hypnotics Sales Market Share Forecast by Country (2027-2032) Table 218. Latin America Non-benzodiazepine Hypnotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 219. Latin America Non-benzodiazepine Hypnotics Market Size by Country (2021-2026) & (US$ Million) Table 220. Latin America Non-benzodiazepine Hypnotics Market Share by Country (2021-2026) Table 221. Latin America Non-benzodiazepine Hypnotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 222. Latin America Non-benzodiazepine Hypnotics Market Share Forecast by Country (2027-2032) Table 223. Middle East and Africa Non-benzodiazepine Hypnotics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 224. Middle East and Africa Non-benzodiazepine Hypnotics Sales by Country (2021-2026) & (K Units) Table 225. Middle East and Africa Non-benzodiazepine Hypnotics Sales Market Share by Country (2021-2026) Table 226. Middle East and Africa Non-benzodiazepine Hypnotics Sales Forecast by Country (2027-2032) & (K Units) Table 227. Middle East and Africa Non-benzodiazepine Hypnotics Sales Market Share Forecast by Country (2027-2032) Table 228. Middle East and Africa Non-benzodiazepine Hypnotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 229. Middle East and Africa Non-benzodiazepine Hypnotics Market Size by Country (2021-2026) & (US$ Million) Table 230. Middle East and Africa Non-benzodiazepine Hypnotics Market Share by Country (2021-2026) Table 231. Middle East and Africa Non-benzodiazepine Hypnotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 232. Middle East and Africa Non-benzodiazepine Hypnotics Market Share Forecast by Country (2027-2032) Table 233. Key Raw Materials Table 234. Raw Materials Key Suppliers Table 235. Non-benzodiazepine Hypnotics Distributors List Table 236. Non-benzodiazepine Hypnotics Customers List Table 237. Research Programs/Design for This Report Table 238. Authors List of This Report Table 239. Secondary Sources Table 240. Primary Sources List of Figures Figure 1. Non-benzodiazepine Hypnotics Image Figure 2. Global Non-benzodiazepine Hypnotics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-benzodiazepine Hypnotics Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-benzodiazepine Hypnotics Sales (2021-2032) & (K Units) Figure 5. Zaleplon Image Figure 6. Global Zaleplon Sales YoY Growth (2021-2032) & (K Units) Figure 7. Zopiclone Image Figure 8. Global Zopiclone Sales YoY Growth (2021-2032) & (K Units) Figure 9. Zolpidem Image Figure 10. Global Zolpidem Sales YoY Growth (2021-2032) & (K Units) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Non-benzodiazepine Hypnotics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Non-benzodiazepine Hypnotics Market Share by Type 2025 VS 2032 Figure 15. North America Non-benzodiazepine Hypnotics Sales Market Share in Volume by Type in 2025 Figure 16. North America Non-benzodiazepine Hypnotics Sales Market Share in Value by Type in 2025 Figure 17. Europe Non-benzodiazepine Hypnotics Sales Market Share in Volume by Type in 2025 Figure 18. Europe Non-benzodiazepine Hypnotics Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Non-benzodiazepine Hypnotics Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Non-benzodiazepine Hypnotics Sales Market Share in Value by Type in 2025 Figure 21. Latin America Non-benzodiazepine Hypnotics Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Non-benzodiazepine Hypnotics Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Non-benzodiazepine Hypnotics Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Non-benzodiazepine Hypnotics Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Non-benzodiazepine Hypnotics Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Non-benzodiazepine Hypnotics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Non-benzodiazepine Hypnotics Market Share by Application 2025 VS 2032 Figure 35. North America Non-benzodiazepine Hypnotics Sales Market Share in Volume by Application in 2025 Figure 36. North America Non-benzodiazepine Hypnotics Sales Market Share in Value by Application in 2025 Figure 37. Europe Non-benzodiazepine Hypnotics Sales Market Share in Volume by Application in 2025 Figure 38. Europe Non-benzodiazepine Hypnotics Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Non-benzodiazepine Hypnotics Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Non-benzodiazepine Hypnotics Sales Market Share in Value by Application in 2025 Figure 41. Latin America Non-benzodiazepine Hypnotics Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Non-benzodiazepine Hypnotics Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Non-benzodiazepine Hypnotics Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Non-benzodiazepine Hypnotics Sales Market Share in Value by Application in 2025 Figure 45. North America Non-benzodiazepine Hypnotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Non-benzodiazepine Hypnotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Non-benzodiazepine Hypnotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Non-benzodiazepine Hypnotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Non-benzodiazepine Hypnotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Non-benzodiazepine Hypnotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Non-benzodiazepine Hypnotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Non-benzodiazepine Hypnotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Non-benzodiazepine Hypnotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Non-benzodiazepine Hypnotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Non-benzodiazepine Hypnotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Non-benzodiazepine Hypnotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Non-benzodiazepine Hypnotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Non-benzodiazepine Hypnotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Non-benzodiazepine Hypnotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Non-benzodiazepine Hypnotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Non-benzodiazepine Hypnotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Non-benzodiazepine Hypnotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Non-benzodiazepine Hypnotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Non-benzodiazepine Hypnotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Non-benzodiazepine Hypnotics Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Non-benzodiazepine Hypnotics Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Zaleplon
  • Zopiclone
  • Zolpidem
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Abbott
  • Tianjin Tasly Saint Pharmaceuticals
  • Sun Pharmaceutical
  • Shanghai Pharmaceuticals
  • Qilu Pharmaceutical
  • Kanghong Pharmaceuticals
  • Changzhou Siyao Pharmaceutical
  • Wockhardt
  • Torrent Pharma
  • Teva Pharmaceuticals
  • Tapi Teva
  • Sanofi-aventis
  • Northstar Rx
  • Mylan Pharmaceuticals
  • Kanghong Pharmaceutical
  • Hikma Pharmaceuticals
  • Glenmark Life Sciences
  • Endo
  • Dr. Reddy’s Laboratories
  • Centaur Pharmaceuticals
  • Apotex
  • Admiron Life

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-benzodiazepine Hypnotics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Non-benzodiazepine Hypnotics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Non-benzodiazepine Hypnotics Market by Type
  6. 1.3.1 Zaleplon
  7. 1.3.2 Zopiclone
  8. 1.3.3 Zolpidem
  9. 1.3.4 Other
  10. 1.4 Global Non-benzodiazepine Hypnotics Market Size by Type
  11. 1.4.1 Global Non-benzodiazepine Hypnotics Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Non-benzodiazepine Hypnotics Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Non-benzodiazepine Hypnotics Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Non-benzodiazepine Hypnotics Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Non-benzodiazepine Hypnotics Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Non-benzodiazepine Hypnotics Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Non-benzodiazepine Hypnotics Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Non-benzodiazepine Hypnotics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Non-benzodiazepine Hypnotics Industry Trends
  2. 2.2 Non-benzodiazepine Hypnotics Industry Drivers
  3. 2.3 Non-benzodiazepine Hypnotics Industry Opportunities and Challenges
  4. 2.4 Non-benzodiazepine Hypnotics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Non-benzodiazepine Hypnotics Revenue (2021-2026)
  2. 3.2 Global Top Players by Non-benzodiazepine Hypnotics Sales (2021-2026)
  3. 3.3 Global Top Players by Non-benzodiazepine Hypnotics Price (2021-2026)
  4. 3.4 Global Non-benzodiazepine Hypnotics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-benzodiazepine Hypnotics Major Company Production Sites & Headquarters
  6. 3.6 Global Non-benzodiazepine Hypnotics Company, Product Type & Application
  7. 3.7 Global Non-benzodiazepine Hypnotics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-benzodiazepine Hypnotics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-benzodiazepine Hypnotics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-benzodiazepine Hypnotics Tier 1, Tier 2, and Tier 3
4 Non-benzodiazepine Hypnotics Regional Status and Outlook
  1. 4.1 Global Non-benzodiazepine Hypnotics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Non-benzodiazepine Hypnotics Historic Market Size by Region
  3. 4.2.1 Global Non-benzodiazepine Hypnotics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Non-benzodiazepine Hypnotics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Non-benzodiazepine Hypnotics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Non-benzodiazepine Hypnotics Forecasted Market Size by Region
  7. 4.3.1 Global Non-benzodiazepine Hypnotics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Non-benzodiazepine Hypnotics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Non-benzodiazepine Hypnotics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Non-benzodiazepine Hypnotics by Application
  1. 5.1 Non-benzodiazepine Hypnotics Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Non-benzodiazepine Hypnotics Market Size by Application
  6. 5.2.1 Global Non-benzodiazepine Hypnotics Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Non-benzodiazepine Hypnotics Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Non-benzodiazepine Hypnotics Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Non-benzodiazepine Hypnotics Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Non-benzodiazepine Hypnotics Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Non-benzodiazepine Hypnotics Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Non-benzodiazepine Hypnotics Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Non-benzodiazepine Hypnotics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Non-benzodiazepine Hypnotics Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Tianjin Tasly Saint Pharmaceuticals
  8. 6.2.1 Tianjin Tasly Saint Pharmaceuticals Company Information
  9. 6.2.2 Tianjin Tasly Saint Pharmaceuticals Business Overview
  10. 6.2.3 Tianjin Tasly Saint Pharmaceuticals Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Tianjin Tasly Saint Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio
  12. 6.2.5 Tianjin Tasly Saint Pharmaceuticals Recent Developments
  13. 6.3 Sun Pharmaceutical
  14. 6.3.1 Sun Pharmaceutical Company Information
  15. 6.3.2 Sun Pharmaceutical Business Overview
  16. 6.3.3 Sun Pharmaceutical Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sun Pharmaceutical Non-benzodiazepine Hypnotics Product Portfolio
  18. 6.3.5 Sun Pharmaceutical Recent Developments
  19. 6.4 Shanghai Pharmaceuticals
  20. 6.4.1 Shanghai Pharmaceuticals Company Information
  21. 6.4.2 Shanghai Pharmaceuticals Business Overview
  22. 6.4.3 Shanghai Pharmaceuticals Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shanghai Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio
  24. 6.4.5 Shanghai Pharmaceuticals Recent Developments
  25. 6.5 Qilu Pharmaceutical
  26. 6.5.1 Qilu Pharmaceutical Company Information
  27. 6.5.2 Qilu Pharmaceutical Business Overview
  28. 6.5.3 Qilu Pharmaceutical Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Qilu Pharmaceutical Non-benzodiazepine Hypnotics Product Portfolio
  30. 6.5.5 Qilu Pharmaceutical Recent Developments
  31. 6.6 Kanghong Pharmaceuticals
  32. 6.6.1 Kanghong Pharmaceuticals Company Information
  33. 6.6.2 Kanghong Pharmaceuticals Business Overview
  34. 6.6.3 Kanghong Pharmaceuticals Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Kanghong Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio
  36. 6.6.5 Kanghong Pharmaceuticals Recent Developments
  37. 6.7 Changzhou Siyao Pharmaceutical
  38. 6.7.1 Changzhou Siyao Pharmaceutical Company Information
  39. 6.7.2 Changzhou Siyao Pharmaceutical Business Overview
  40. 6.7.3 Changzhou Siyao Pharmaceutical Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Changzhou Siyao Pharmaceutical Non-benzodiazepine Hypnotics Product Portfolio
  42. 6.7.5 Changzhou Siyao Pharmaceutical Recent Developments
  43. 6.8 Wockhardt
  44. 6.8.1 Wockhardt Company Information
  45. 6.8.2 Wockhardt Business Overview
  46. 6.8.3 Wockhardt Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Wockhardt Non-benzodiazepine Hypnotics Product Portfolio
  48. 6.8.5 Wockhardt Recent Developments
  49. 6.9 Torrent Pharma
  50. 6.9.1 Torrent Pharma Company Information
  51. 6.9.2 Torrent Pharma Business Overview
  52. 6.9.3 Torrent Pharma Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Torrent Pharma Non-benzodiazepine Hypnotics Product Portfolio
  54. 6.9.5 Torrent Pharma Recent Developments
  55. 6.10 Teva Pharmaceuticals
  56. 6.10.1 Teva Pharmaceuticals Company Information
  57. 6.10.2 Teva Pharmaceuticals Business Overview
  58. 6.10.3 Teva Pharmaceuticals Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Teva Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio
  60. 6.10.5 Teva Pharmaceuticals Recent Developments
  61. 6.11 Tapi Teva
  62. 6.11.1 Tapi Teva Company Information
  63. 6.11.2 Tapi Teva Business Overview
  64. 6.11.3 Tapi Teva Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Tapi Teva Non-benzodiazepine Hypnotics Product Portfolio
  66. 6.11.5 Tapi Teva Recent Developments
  67. 6.12 Sanofi-aventis
  68. 6.12.1 Sanofi-aventis Company Information
  69. 6.12.2 Sanofi-aventis Business Overview
  70. 6.12.3 Sanofi-aventis Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Sanofi-aventis Non-benzodiazepine Hypnotics Product Portfolio
  72. 6.12.5 Sanofi-aventis Recent Developments
  73. 6.13 Northstar Rx
  74. 6.13.1 Northstar Rx Company Information
  75. 6.13.2 Northstar Rx Business Overview
  76. 6.13.3 Northstar Rx Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Northstar Rx Non-benzodiazepine Hypnotics Product Portfolio
  78. 6.13.5 Northstar Rx Recent Developments
  79. 6.14 Mylan Pharmaceuticals
  80. 6.14.1 Mylan Pharmaceuticals Company Information
  81. 6.14.2 Mylan Pharmaceuticals Business Overview
  82. 6.14.3 Mylan Pharmaceuticals Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Mylan Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio
  84. 6.14.5 Mylan Pharmaceuticals Recent Developments
  85. 6.15 Kanghong Pharmaceutical
  86. 6.15.1 Kanghong Pharmaceutical Company Information
  87. 6.15.2 Kanghong Pharmaceutical Business Overview
  88. 6.15.3 Kanghong Pharmaceutical Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Kanghong Pharmaceutical Non-benzodiazepine Hypnotics Product Portfolio
  90. 6.15.5 Kanghong Pharmaceutical Recent Developments
  91. 6.16 Hikma Pharmaceuticals
  92. 6.16.1 Hikma Pharmaceuticals Company Information
  93. 6.16.2 Hikma Pharmaceuticals Business Overview
  94. 6.16.3 Hikma Pharmaceuticals Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Hikma Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio
  96. 6.16.5 Hikma Pharmaceuticals Recent Developments
  97. 6.17 Glenmark Life Sciences
  98. 6.17.1 Glenmark Life Sciences Company Information
  99. 6.17.2 Glenmark Life Sciences Business Overview
  100. 6.17.3 Glenmark Life Sciences Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Glenmark Life Sciences Non-benzodiazepine Hypnotics Product Portfolio
  102. 6.17.5 Glenmark Life Sciences Recent Developments
  103. 6.18 Endo
  104. 6.18.1 Endo Company Information
  105. 6.18.2 Endo Business Overview
  106. 6.18.3 Endo Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Endo Non-benzodiazepine Hypnotics Product Portfolio
  108. 6.18.5 Endo Recent Developments
  109. 6.19 Dr. Reddy’s Laboratories
  110. 6.19.1 Dr. Reddy’s Laboratories Company Information
  111. 6.19.2 Dr. Reddy’s Laboratories Business Overview
  112. 6.19.3 Dr. Reddy’s Laboratories Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Dr. Reddy’s Laboratories Non-benzodiazepine Hypnotics Product Portfolio
  114. 6.19.5 Dr. Reddy’s Laboratories Recent Developments
  115. 6.20 Centaur Pharmaceuticals
  116. 6.20.1 Centaur Pharmaceuticals Company Information
  117. 6.20.2 Centaur Pharmaceuticals Business Overview
  118. 6.20.3 Centaur Pharmaceuticals Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Centaur Pharmaceuticals Non-benzodiazepine Hypnotics Product Portfolio
  120. 6.20.5 Centaur Pharmaceuticals Recent Developments
  121. 6.21 Apotex
  122. 6.21.1 Apotex Company Information
  123. 6.21.2 Apotex Business Overview
  124. 6.21.3 Apotex Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Apotex Non-benzodiazepine Hypnotics Product Portfolio
  126. 6.21.5 Apotex Recent Developments
  127. 6.22 Admiron Life
  128. 6.22.1 Admiron Life Company Information
  129. 6.22.2 Admiron Life Business Overview
  130. 6.22.3 Admiron Life Non-benzodiazepine Hypnotics Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Admiron Life Non-benzodiazepine Hypnotics Product Portfolio
  132. 6.22.5 Admiron Life Recent Developments
7 North America by Country
  1. 7.1 North America Non-benzodiazepine Hypnotics Sales by Country
  2. 7.1.1 North America Non-benzodiazepine Hypnotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Non-benzodiazepine Hypnotics Sales by Country (2021-2026)
  4. 7.1.3 North America Non-benzodiazepine Hypnotics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Non-benzodiazepine Hypnotics Market Size by Country
  6. 7.2.1 North America Non-benzodiazepine Hypnotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Non-benzodiazepine Hypnotics Market Size by Country (2021-2026)
  8. 7.2.3 North America Non-benzodiazepine Hypnotics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Non-benzodiazepine Hypnotics Sales by Country
  2. 8.1.1 Europe Non-benzodiazepine Hypnotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Non-benzodiazepine Hypnotics Sales by Country (2021-2026)
  4. 8.1.3 Europe Non-benzodiazepine Hypnotics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Non-benzodiazepine Hypnotics Market Size by Country
  6. 8.2.1 Europe Non-benzodiazepine Hypnotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Non-benzodiazepine Hypnotics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Non-benzodiazepine Hypnotics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Non-benzodiazepine Hypnotics Sales by Country
  2. 9.1.1 Asia-Pacific Non-benzodiazepine Hypnotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Non-benzodiazepine Hypnotics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Non-benzodiazepine Hypnotics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Non-benzodiazepine Hypnotics Market Size by Country
  6. 9.2.1 Asia-Pacific Non-benzodiazepine Hypnotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Non-benzodiazepine Hypnotics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Non-benzodiazepine Hypnotics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Non-benzodiazepine Hypnotics Sales by Country
  2. 10.1.1 South America Non-benzodiazepine Hypnotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Non-benzodiazepine Hypnotics Sales by Country (2021-2026)
  4. 10.1.3 South America Non-benzodiazepine Hypnotics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Non-benzodiazepine Hypnotics Market Size by Country
  6. 10.2.1 South America Non-benzodiazepine Hypnotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Non-benzodiazepine Hypnotics Market Size by Country (2021-2026)
  8. 10.2.3 South America Non-benzodiazepine Hypnotics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Non-benzodiazepine Hypnotics Sales by Country
  2. 11.1.1 Middle East and Africa Non-benzodiazepine Hypnotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Non-benzodiazepine Hypnotics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Non-benzodiazepine Hypnotics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Non-benzodiazepine Hypnotics Market Size by Country
  6. 11.2.1 Middle East and Africa Non-benzodiazepine Hypnotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Non-benzodiazepine Hypnotics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Non-benzodiazepine Hypnotics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Non-benzodiazepine Hypnotics Value Chain Analysis
  2. 12.1.1 Non-benzodiazepine Hypnotics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Non-benzodiazepine Hypnotics Production Mode & Process
  7. 12.2 Non-benzodiazepine Hypnotics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Non-benzodiazepine Hypnotics Distributors
  10. 12.2.3 Non-benzodiazepine Hypnotics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst